NCT02230995 Bioequivalence of a Fixed Dose Combination Tablet of Empagliflozin/Metformin Extended Release Compared With Mono Compound Tablets in Healthy Subjects Status COMPLETED Phase PHASE1
NCT02221414 Bioequivalence of a 2.5 mg Linagliptin / 500 mg Metformin Fixed Dose Combination Tablet Compared With Single Linagliptin 2.5 mg and Metformin 500 mg Tablets Administered Together in Healthy Volunteers Status COMPLETED Phase PHASE1
NCT02221401 Bioequivalence of a Linagliptin / Metformin Fixed-dose Combination (FDC) Tablet Compared With Single Linagliptin and Metformin Tablets Administered Together in Healthy Volunteers Status COMPLETED Phase PHASE1
NCT02221180 Bioequivalence Study of Metformin Component of Fixed Dose Combination (FDC) Immediate Release (IR) Tablet of Canagliflozin and Metformin Compared to Metformin IR Tablet Co-administered With Canagliflozin in Healthy Fed and Fasted Participants Status COMPLETED Phase PHASE1
NCT02220647 Bioequivalence of a 2.5 mg Linagliptin / 850 mg Metformin Fixed Dose Combination Tablet Compared With Single Linagliptin 2.5 mg and Metformin 850 mg Tablets in Healthy Volunteers Status COMPLETED Phase PHASE1
NCT02205528 A Study of Once-Daily NNC0090-2746 in Participants With Type 2 Diabetes Inadequately Controlled With Metformin Status COMPLETED Phase PHASE2
NCT02202161 A Study Investigating Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GSK2330672 Administered With Metformin to Type 2 Diabetes Patients Status COMPLETED Phase PHASE2
NCT02190838 Comparison of Melatonin or Metformin and Dacarbazine Combination Versus Dacarbazine Alone in Disseminated Melanoma Status TERMINATED Phase PHASE2
NCT02187250 PDE-4 Inhibitor Roflumilast and GLP-1 Agonist Liraglutide in Polycystic Ovary Syndrome Status COMPLETED Phase PHASE4
NCT02186847 Chemotherapy and Radiation Therapy With or Without Metformin Hydrochloride in Treating Patients With Stage III Non-small Cell Lung Cancer Status COMPLETED Phase PHASE2
NCT02186483 Clinical Trial to Investigate the Pharmacokinetics Drug Interaction Between Metformin and Rosuvastatin Status COMPLETED Phase PHASE1
NCT02183506 Bioavailability of BI 1356 BS and Metformin After Co-administration Compared to the Bioavailability of BI 1356 BS Alone and Metformin Alone in Healthy Male Volunteers Status COMPLETED Phase PHASE1
NCT02173639 Bioavailability of Combination Tablet BI 1356/Metformin Compared With Single BI 1356 and Metformin Administered Together to Healthy Male and Female Subjects Status COMPLETED Phase PHASE1
NCT02172248 Relative Bioavailability BI 10773 and Metformin in Healthy Male Volunteers Status COMPLETED Phase PHASE1
NCT02167620 Metformin in Co-morbid Diabetes or Prediabetes and Serious Mental Illness Status COMPLETED Phase PHASE4
NCT02152371 A Study of Dulaglutide (LY2189265) in Participants With Type II Diabetes Status COMPLETED Phase PHASE3
NCT02151461 Dose Comparisons of Leucine-Metformin Combinations on Blood Glucose Levels In Type 2 Diabetic Patients Status COMPLETED Phase PHASE2